Drug Profile
Research programme: antibody-drug conjugates - AGC biologics/IDT Biologika
Latest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator CMC Biologics; IDT Biologika GmbH
- Developer AGC Biologics; IDT Biologika GmbH
- Class Antibodies; Drug conjugates
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer